CLCM
ARRY

Crawford Lake Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Crawford Lake Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-332,356
Closed -$5.42M – 127
2018
Q1 		$5.42M Buy
+332,356
New +$5.32M 1.16% 29

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Crawford Lake Capital Management's ARRY Position: Q2 2018 in Review

Crawford Lake Capital Management sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 332,356 shares — an estimated $5.42M sold.

Crawford Lake Capital Management first reported a position in ARRY in Q1 2018 and held it in 1 quarter. The position peaked at $5.42M in Q1 2018. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Crawford Lake Capital Management reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Crawford Lake Capital Management sold 332,356 Array Biopharma Inc shares in Q2 2018, an estimated $5.42M.
  • Crawford Lake Capital Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 1 quarter.
  • Crawford Lake Capital Management's Array Biopharma Inc position peaked at $5.42M in Q1 2018.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Crawford Lake Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.